Dosimetry of an iodine-123-labeled tropane to image dopamine transporters

Journal of Nuclear Medicine

Volumn 37, Issue 1, 1996, Pages 151-159

  Mozley, P David ^a   Stubbs, James B ^b   Kim, Hee Joung ^b   McElgin, Will ^b   Kung, Mei Ping ^b   Meegalla, Sanath ^b   Kung, Hank F ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

dopamine transporter; dosimetry; iodine 123 tropane; SPECT

Indexed keywords

COCAINE DERIVATIVE; DOPAMINE RECEPTOR; IODINE 123; TROPANE DERIVATIVE;

ADULT; ARTICLE; DOPAMINE BRAIN LEVEL; DOSIMETRY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMAGE ENHANCEMENT; KIDNEY SCINTISCANNING; MALE; NORMAL HUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; SYNAPTIC MEMBRANE; URINALYSIS; URINARY EXCRETION;

ADULT; BASAL GANGLIA; CARRIER PROTEINS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IODINE RADIOISOTOPES; KIDNEY; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RADIATION DOSAGE; TIME FACTORS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 0029989617     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Cooper JR, Bloom FE, Roth RH. The biological basis of neuropharmacology 6th ed New York. Oxford University Press. 1991:292-294.
2. Johanson CE, Fischman M The pharmacology of cocaine related to its abuse Pharmacol Rev 1989;41:3-52.
3. Carroll FI, Abram P, Lewin AH, Parham K, Boja JW, Kuhar MJ Isopropyl and phenyl esters of 3b-(4-substituted phenyl)Tropan-2b-carboxyhc acids: potent and selective compounds for the dopamine transporter J Med Chem 1992;35:2497-2500.
4. Madras B, Spealman R, Fahey M, Neumeyer J, Saha J, Milius R. Cocaine receptors labeled by [3H]2b-carbomethoxy-3b-(4-fluorophenyl)tropane. Mol Pharmacol 1989; 36:518-524.
5. Kung M-P, Essman WD, Frederick D, et al. IPT: a novel iodinated ligand for the CNS dopamine transporter. Synapse 1995;20 316-324.
6. Goodman MM, Mung M-P, Kabalka GW, Kung HF, Switzer R. Synthesis and characterization of radioiodinated N-(3-Iodopropen-1-yl)2B-carbomethoxy-3B-(4-chlorophenyl) tropanes: potential dopamine reuptake site imaging agents. J Med Chem 1994;37.1535-1542.
7. Malison RT, Vessotskie J, Kung M-P, et al SPECT imaging of striatal dopamine transporters in non-human primates with [I-123]IPT. J Nucl Med 1995,36:2290-2297.
8. Mozley PD, Kim H-J, Stubbs JB, et al. Brain and cardiac uptake of I-123 IPT: an analog of cocaine [Abstract]. J Nucl Med 1994;35(suppl):129P.
9. Sorenson JA, Phelps ME: Internal radiation dosimetry. In: Physics in nuclear medicine. 2nd ed Philadelphia. W.B. Saunders; 1987:197-218.
10. Budinger TF, Gullberg GT, Huesman RH. Emission computed tomography. In: Herman GT, ed. Image reconstruction from projections. Berlin Springer-Verlag; 1979:147-242 (Topics in Applied Radiology, vol. 32).
11. Budinger TF, Gullberg GT, Huesman RH. Emission computed tomography. In: Herman GT, ed. Image reconstruction from projections. Berlin Springer-Verlag; 1979:147-242 (Topics in Applied Radiology, vol. 32).
12. 123I dynamic SPECT imaging [Abstract]. J Nucl Med 1993,34(suppl):190.
13. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978;NS-25:638-643.
14. Jones JP, Brill AB, Johnson RE The validity of an equivalent point source assumption used in quantitative scanning. Phys Med Biol 1975,20:455-464.
15. Thomas SR, Maxon HR In vivo quantitation of lesion radioactivity using external counting methods. Med Phys 1976;3 253-255.
16. Robertson J. Compartmental distribution of radiotracers. Boca Raton. FL: CRC Press; 1983.
17. Stubbs JB, Smith GT, Stabin MG, Eckerman KF, Turner JE. An approach to cellular level dosimetry using compartmental model analysis and dynamic PET. Watson EE, Schlafke-Stelson A, eds Proceedings of the fifth international symposium on radiopharmaceutical dosimetry. May 1991;385-395.
18. Stabin M, Taylor A Jr, Eshima D, Wooter W. Radiation dosimetry for technetium-99m-MAG3, technctium-99m-DTPA and iodine-131-OIH based on human biodistribution studies. J Nucl Med 1992,33 33-40.
19. Mozley PD, Stubbs JS. Kung HF, Selickson MH, Stabin MG, Alavi A. Biodistribution and Dosimetry of I-123 IBF: a potent radioligand for imaging the D2 dopamine receptor. J Nucl Med 1993,34:1910-1917.
20. Mozley PD, Stubbs JB, Kim H-J, et al. Biodistnbution and dosimetry of a D2/D3 dopamine receptor antagonist that can be used with either PET or SPECT. J. Nucl Med 1995;35.1322-1331.
21. Cloutier RJ, Smith SA, Watson EE, Snyder WS, Warner GG. Dose to the fetus from radionuclides in the bladder. Health Phys 1973;25.147-161.
22. International Commission on Radiation Protection. ICRP publication 30. Limits for intake of radionuclides by workers. New York: Pergamon Press, 1979.
23. International Commission on Radiation Protection. ICRP publication 23. Report of the task group on reference man. Oxford: Pergamon Press; 1979.
24. Loevinger R, Berman M A revised schema for calculating the absorbed dose from biologically distributed radionuclides. MlRD pamphlet no. 1 (revised). New York: Society of Nuclear Medicine: 1975.
25. Cristy M, Eckerman K Specific absorbed fractions of energy at various ages from internal photon sources. Oak Ridge, TN: ORNL/TM-8381 1987.
26. Snyder WS, Ford MR, Warner GG, Watson SB. "S" absorbed dose per unit cumulated activity for selected radionucitdes and organs MIRD pamplet no II. New York: Society of Nuclear Medicine: 1975.
27. Lange RA, Cigarroa RG, Yancey CW Jr, et al. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med 1989;321:1157-1162.
28. Moliterno DJ, Willard JE, Lange RA, et al Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. N Engl J Med 1994;330:454-459.
29. National Council of Radiation Protection and Measurements. NCRP report No. 39, Basic Radiation Protection Criteria. Washington D C.: National Council of Radiation Protection and Measurements; 1971.
30. Food and Drug Administration. HHS: Radioactive drugs for certain research uses. Code of Federal Regulations (CFR) 21, Ch 1 (4-1-89 Edition), Part 361.1, paragraph (b) (3) (1), p. 206.
31. National Council on Radiation Protection and Measurement (NCRP). Protection of the thyroid gland in the event of releases of radioiodine. Washington, D.C., NCRP report no 55, August 1, 1977.
32. Mejia AA, Nakamura T, Masatoshi I, Hatazawa J, Masaki M, Watanuki S. Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies. J Nucl Med 1991;32:699-706.
33. Kuikka JT, Bergstrom KA, Ahonen A, Lansimies E. The dosimetry of iodine-123 labelled 2-carbomethoxy-3-(4-iodophenyl)tropane Eur J Nucl Med 1994;21 53-56.
34. Neumeyer JL, Wang S, Milius RA, et al. [123I]-2b-Carbomethoxy-3b-(4-iodophenyl)tropane, high-affinity SPFCT radiotracer of monoamine reuptake sites in brain. J Med Chem 1991;34:3144-3146.